Anti-HIV-1 activity of carborane derivatives of porphyrins

Medicinal Chemistry Research

Volumn 9, Issue 4, 1999, Pages 267-275

  Debnath, Asim K ^a   Jiang, Shibo ^a   Strick, Nathan ^a   Lin, Kang ^a   Kahl, Stephen B ^b   Neurath, A Robert ^a  

^a NEW YORK BLOOD CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBORANE DERIVATIVE; CD4 ANTIGEN; GLYCOPROTEIN GP 120; MONOCLONAL ANTIBODY; PORPHYRIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; COST BENEFIT ANALYSIS; DRUG PROTEIN BINDING; DRUG SELECTIVITY; DRUG STRUCTURE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION;

EID: 0032822696     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Deeks, S.G., Smith, M., Holodniy, M., and Kahn, J.O. HIV-1 protease inhibitors: A review for clinicians. J. Am. Med. Assoc. 1997, 277, 145-153.
2. Neurath, A.R., Haberfield, P., Joshi, B., Hewlett, I.K., Strick, N., and Jiang, S. Rapid prescreening for antiviral agents against HW-1 based on their inhibitory activity in site-directed immunoassays I. The V3 loop of gp120 as target. Antiviral Chem. Chemother. 1991, 2, 303-312.
3. Neurath, A.R., Strick, N., Haberfield, P., and Jiang, S. Rapid prescreening for antiviral agents against HIV-1 based on their inhibitory activity in site-directed immunoassays. II. Porphyrins reacting with the V3 loop of gp120. Antiviral Chem. Chemother. 1992, 3, 55-63.
4. Neurath, A.R., Strick, N., Lin, K., Debnath, A.K., and Jiang, S. Tin protoporphyrin IX used in control of heme metabolism in humans effectively inhibits HIV-1 infection. Antiviral Chem. Chemother. 1994, 5, 322-330.
5. Neurath, A.R., Strick, N., and Debnath, A.K. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120. J. Mol. Recog., 1995, 8, 345-357.
6. Debnath, A.K., Jiang, S., Strick, N., Lin, K., Haberfield, P., and Neurath, A.R. Three-dimensional structure-activity analysis of a series of porphyrin derivatives with anti-HIV-1 activity targeted to the V3 loop of the gp120 envelope glycoprotein of the human immunodeficiency virus type 1. J. Med. Chem. 1994, 37, 1099-1108.
7. DeCamp, D.L., Babe, L.M., Salto, R., Lucich, J.L., Koo, M.-S., Kahl, S.B. and Craick, C.S. Specific inhibition of HIV-1 protease by boronated porphyrins. J. Med. Chem. 1992, 35, 3426-3428.
8. Asanaka, K.E., Kurimura, T., Toya, H., Ogaki, J., and Karo, Y. Anti-HIV activity of porphyrin. AIDS, 1989, 3, 403-404.
9. Dixon, D.W., Schinazi, R.F., and Marzilli, L.G. Porphyrins are agents against the human immunodeficiency virus. Ann. NY Acad. Sci., 1990, 616, 511-513.
10. Dixon, D.W., Kim, M.S., Kumar, V., Obara, G., Marzilli, L.G., and Schinazi, R.F. Amino- and hydroxytetraphenylporphyrins with activity against the human immunodeficiency virus. Antiviral Chem. Chemother., 1992, 3, 279-282.
11. Levere, R.D., Gong, Y.-F., Kappas, A., Bucher, D.J., Wormser, G.P., and Abraham, N.G. Heme inhibits human immunodeficiency virus 1 replication in cell cultures and enhances the antiviral effect of zidovudine. Proc. Natl. Acad. Sci. USA, 1991, 88, 1756-1759.
12. Fairchild, R.G., Kahl, S.B., Laster, B.H., Kalef-Ezra, J., and Popenoe, E.A. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res., 1990, 50, 4860-4865.
13. Kahl, S.B., and Koo, M.-S. Synthesis of tetrakis-carborane carboxylate esters of 2,4-di(α, β-dihydroxyethyl)-deuteroporphyrin IX. J. Chem. Soc. Chem. Commun., 1990, 1769-1771.
14. Kahl, S.B., Schaeck, J.S., and Koo, M.-S. Improved methods for the synthesis of porphyrin alcohols and aldehydes from protoporphyrin IX dimethyl ester and their further modification. J. Org. Chem., 1997, 62, 1875-1880.